Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · MOZ

Acid, Hyaluronic, Intraarticular

FDA classification: Unknown. Device class 3.

Product / regulatory recordCompanyPathwayDecision dateSource
Gel-OneP080020/S056
Seikagaku Corp.PMA supplementSep 4, 2026FDA
SUPARTZ FXP980044/S067
Seikagaku Corp.PMA supplementSep 4, 2026FDA
Ferring Pharmaceuticals, Inc.PMA supplementSep 2, 2026FDA
Anika Therapeutics, Inc.PMA supplementAug 28, 2026FDA
GEL-ONEP080020/S057
Seikagaku Corp.PMA supplementAug 26, 2026FDA
SUPARTZ FXP980044/S068
Seikagaku Corp.PMA supplementAug 26, 2026FDA
Gelsyn-3P110005/S015
Ibsa Institut Biochimique SAPMA supplementJul 24, 2026FDA
GEL-ONEP080020/S055
Seikagaku Corp.PMA supplementApr 9, 2026FDA
DUROLANEP170007/S015
Bioventus, LLCPMA supplementDec 23, 2025FDA
SYNOJOYNTP170016/S001
MesoblastPMA supplementDec 23, 2025FDA
Seikagaku Corp.PMA supplementDec 19, 2025FDA
Ferring Pharmaceuticals, Inc.PMA supplementOct 16, 2025FDA
SUPARTZ FXP980044/S064
Seikagaku Corp.PMA supplementAug 18, 2025FDA
Seikagaku Corp.PMA supplementJul 22, 2025FDA
GEL-ONEP080020
Seikagaku Corp.PMA approvalMar 22, 2011FDA
Ferring Pharmaceuticals, Inc.PMA approvalDec 3, 2004FDA
SUPARTZ FXP980044
Seikagaku Corp.PMA approvalJan 24, 2001FDA
Source information

Follow the FDA links to view the original records.

All device categories